A Congressional Budget Office (CBO) document released quietly on Thursday hinted at a major gaffe by the budget agency and its efforts to conceal that gaffe.
A major anti-addiction nonprofit organization is getting big bucks from the pharmaceutical industry. Whose interests are the American Society of Addiction Medicine serving?
The rising costs of many, if not all, medications are largely the result of the lack of competition in the pharmaceutical industry. That’s the FDA’s fault.
While the public hold little sympathy for Big Pharma, when the drug industry suffers, people suffer. And when Big Pharma wins, people win.
The Left insists that the 21st Century Cures Act’s regulatory updates to allow high-need patients to try out new drugs will mean more death and suffering. In fact, the opposite is true.
Sound bites often prevent an honest dialogue about the causes of high drug prices and the consequences of government intervention.
Watch out for five misguided attacks to persuade the public that government intervention in the pharmaceutical industry is necessary. Actually, it will make things worse.
- Top Mueller Officials Coordinated With Fusion GPS Spouse In 2016The Department of Justice's Bruce Ohr claimed he repeatcontinue reading >
- Anti-Gun Democrat’s Purchase Of ‘MeatEater’ Could Pose Big Problems For Hunter-Focused CompanyPeter Chernin, an anti-gun Democrat who called for a fecontinue reading >
- Alexandria Ocasio-Cortez Is Setting Women Back Light Years In PoliticsShe doesn't deserve to be lauded as millennials' feminicontinue reading >